Previous close | 1.2500 |
Open | N/A |
Bid | 0.1000 |
Ask | 0.8500 |
Strike | 47.50 |
Expiry date | 2024-06-21 |
Day's range | 1.2500 - 1.2500 |
Contract range | N/A |
Volume | |
Open interest | 22 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.